Drug Profile
Factor IX - Prothya BioSolutions
Alternative Names: NonafactLatest Information Update: 22 Dec 2021
Price :
$50
*
At a glance
- Originator Sanquin Blood Supply Foundation
- Developer Prothya BioSolutions
- Class Antihaemorrhagics; Blood coagulation factors
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemophilia B